USD 433.64 million
Renal Denervation Market Size, Share, Growth Analysis, By Product (Simplicity, Vessix (V2)), By Technology (Radiofrequency, Ultrasound), By End-Users (Hospital, Clinics), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35J2095 |
Region:
Global |
Published Date: December, 2024
Pages:
157
|Tables:
63
|Figures:
75
Renal Denervation Market Insights
Global Renal Denervation Market size was valued at USD 433.64 million in 2023 and is poised to grow from USD 610.13 million in 2024 to USD 9370.79 million by 2032, growing at a CAGR of 40.7% during the forecast period (2025-2032).
The global renal denervation market has witnessed significant growth in recent years and is expected to continue its upward trajectory. Renal denervation is a minimally invasive procedure used to treat hypertension (high blood pressure) by disrupting the renal nerves responsible for regulating blood pressure. The growing prevalence of hypertension worldwide, coupled with the increasing awareness about the benefits of renal denervation, has fueled market growth. One of the key drivers of the renal denervation market is the rising incidence of hypertension, which is a major risk factor for cardiovascular diseases. As hypertension remains a global health concern, there is a growing demand for effective treatment options like renal denervation. Furthermore, the procedure offers advantages such as reduced reliance on medication and improved patient outcomes, driving its adoption among healthcare providers and patients. In addition, advancements in technology and medical devices have contributed to the market growth. Renal denervation procedures now involve the use of innovative catheter systems equipped with radiofrequency or ultrasound energy to selectively ablate the renal nerves. These technological advancements have improved the precision and safety of the procedure, further bolstering its adoption. However, the renal denervation market also faces certain challenges. One major challenge is the lack of long-term clinical data demonstrating the sustained efficacy and safety of the procedure. Although early studies have shown promising results, further evidence is needed to establish renal denervation as a standard treatment option for hypertension. Additionally, reimbursement policies and regulatory barriers in some regions may hinder the widespread adoption of renal denervation procedures. Despite these challenges, the global renal denervation market is expected to grow as more clinical data emerges and healthcare systems recognize the potential of this procedure in managing hypertension. The market offers significant opportunities for medical device manufacturers and healthcare providers to develop innovative technologies and expand their offerings.
US Renal Denervation Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
radiofrequency
Fastest Growth
radiofrequency
Growth Rate
40.7% CAGR
Global Renal Denervation Market ($ Bn)
Country Share for Europe Region (%)
To get more reports on the above market click here to Buy The Report
Renal Denervation Market Segmental Analysis
Global Renal Denervation Market is segmented by product, technology, end-users and region. Based on product, the market is segmented into simplicity, vessix (V2), enlightn, paradise, iberis and others. Based on technology, the market is segmented into radiofrequency, ultrasound, micro-infusion and others. Based on end-users, the market is segmented into hospital, clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Renal Denervation Market Analysis By Type
The global renal denervation market can be segmented by type into catheters, RF generators, and nerve modifying agents. Among these segments, catheters hold the dominant position in the market. Catheters are essential devices used in renal denervation procedures to deliver energy or medications to the targeted renal nerves. They are available in various designs, including radiofrequency and ultrasound catheters, and play a vital role in the success and efficacy of the procedure. In terms of the fastest-growing segment, nerve modifying agents are gaining momentum in the renal denervation market. Nerve modifying agents are pharmacological substances that can be used in combination with catheter-based procedures to modulate renal nerves and achieve blood pressure reduction. These agents may include neurotoxic substances or other compounds that can selectively target and modulate nerve activity. The development of novel nerve modifying agents and their potential to enhance the outcomes of renal denervation procedures are driving their growth in the market.
Renal Denervation Market Analysis By Technology
The global renal denervation market can be segmented by technology into radiofrequency, ultrasound, and micro-infusion. Among these, radiofrequency technology has emerged as the dominant segment in the market. Radiofrequency renal denervation involves the use of catheters that deliver controlled radiofrequency energy to ablate the renal nerves, thereby reducing blood pressure. This technology has gained widespread acceptance due to its effectiveness and relatively long-standing presence in the market.
On the other hand, the fastest-growing segment in the renal denervation market is ultrasound technology. Ultrasound-based renal denervation utilizes catheters equipped with ultrasound transducers to deliver focused ultrasound energy to disrupt the renal nerves. This technology is gaining traction due to its non-thermal nature, which offers potential advantages in terms of safety and precision. The evolving ultrasound technology and ongoing research are driving its adoption and fueling its growth in the renal denervation market.
Global Renal Denervation Market By Technology
To get detailed analysis on other segments, Request For Free Sample Report
Renal Denervation Market Regional Insights
The global renal denervation market can be segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these regions, Europe holds the dominant position in the global market. Europe has been at the forefront of renal denervation research and adoption, with several countries implementing the procedure as a treatment option for hypertension. The region has witnessed significant investments in research and development, along with favorable reimbursement policies, which have contributed to the market's dominance in Europe.
In terms of the fastest-growing region, Asia Pacific is experiencing notable growth in the renal denervation market. The region is witnessing an increasing prevalence of hypertension, attributed to lifestyle changes, urbanization, and an aging population. As a result, there is a growing demand for effective treatment options such as renal denervation. Moreover, rising healthcare expenditure, improving healthcare infrastructure, and expanding awareness about hypertension management in countries like China, India, and Japan are driving the growth of the renal denervation market in Asia Pacific.
Global Renal Denervation Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Renal Denervation Market Dynamics
Renal Denervation Market Drivers
Technological Advancements
- Advancements in renal denervation technologies, such as improved catheter designs, enhanced energy delivery systems, and innovative nerve modifying agents, are driving market growth. These advancements enhance the precision, safety, and effectiveness of the procedure.
Growing Awareness and Acceptance
- Increasing awareness about the benefits of renal denervation among patients and healthcare providers is driving market growth. The procedure offers advantages such as reduced reliance on medication, improved blood pressure control, and potential long-term benefits.
Renal Denervation Market Restraints
Limited Awareness and Adoption in Emerging Markets
- In some emerging markets, there may be limited awareness and understanding of renal denervation as a treatment option for hypertension. Lack of awareness, coupled with limited healthcare infrastructure, can pose restraints on market growth in these regions.
Procedural Complexity and Learning Curve
- Renal denervation is a technically complex procedure that requires specialized training and expertise. The procedural complexity and the learning curve associated with renal denervation may limit its widespread adoption, particularly among less-experienced healthcare providers.
Request Free Customization of this report to help us to meet your business objectives.
Renal Denervation Market Competitive Landscape
The competitive landscape of the global renal denervation market is characterized by intense competition among various players in the industry. The market is witnessing the participation of numerous medical device manufacturers, research institutions, and healthcare providers striving to develop innovative technologies and treatment approaches for renal denervation. These players are focused on advancing the field through research and development activities, collaborations, and strategic partnerships. The competitive landscape is driven by factors such as technological advancements, product launches, regulatory approvals, and market expansion strategies. Companies are investing significant resources in developing advanced catheter systems, refining energy delivery mechanisms, and exploring novel nerve modifying agents. Moreover, the market is witnessing collaborations between medical device manufacturers, research institutions, and healthcare providers to conduct clinical trials, gather evidence, and enhance the understanding of renal denervation. In addition to established medical device manufacturers, several startups and emerging companies are also entering the market, introducing novel approaches and technologies to the field of renal denervation. This dynamic landscape fosters competition and innovation, as companies strive to gain a competitive edge and capture a larger market share.
Renal Denervation Market Top Player’s Company Profiles
- Medtronic (Ireland)
- Symap Medical (China)
- Shanghai Golden Leaf Medtec (China)
- Shanghai Wisegain Medical Devices (China)
- Terumo Corporation (Japan)
- Abbott Laboratories (USA)
- Johnson & Johnson (USA)
- Boston Scientific (USA)
- St. Jude Medical (USA)
- Cordis Corporation (USA)
- Vessix Vascular (USA)
- Ardian (USA)
- Otsuka Holdings (Japan)
Renal Denervation Market Recent Developments
- In March 2022, the enrollment phase of the RADIANCE-II pivotal trial, conducted by ReCor Medical Inc., a subsidiary of Otsuka Medical Devices Co., Ltd, has been successfully concluded. This trial focused on evaluating the efficacy and safety of the Paradise Ultrasound Renal Denervation (uRDN) System for the treatment of uncontrolled hypertension. The completion of enrollment marks an important milestone in the development of this innovative technology and brings us one step closer to potentially providing a promising solution for patients with uncontrolled hypertension.
- In May 2022, During EuroPCR 2022, Medtronic PLC presented new data demonstrating the positive outcomes of the Symplicity Spyral Renal Denervation (RDN) system in achieving target blood pressure levels. The data, obtained from the SPYRAL HTN Global Clinical Program, specifically from the SPYRAL HTN-ON MED and GSR-DEFINE studies, spanned a period of three years. This release of data highlights the potential benefits of the Symplicity Blood Pressure Procedure in effectively managing blood pressure levels and showcases the ongoing advancements in the field of renal denervation.
Renal Denervation Key Market Trends
- Shift towards Ambulatory Settings: There is a trend towards performing renal denervation procedures in ambulatory or outpatient settings rather than in hospitals. This shift is driven by factors such as cost-effectiveness, patient convenience, and reduced hospitalization requirements. Performing renal denervation in ambulatory settings can enhance patient access and contribute to the growth of the market.
- Patient-Centric Approach: Healthcare providers and companies in the renal denervation market are increasingly adopting a patient-centric approach. The focus is on delivering personalized care, improving patient outcomes, and enhancing patient experience throughout the entire renal denervation process. This trend aligns with the broader shift towards value-based healthcare.
Renal Denervation Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global renal denervation market analysis, the market is experiencing significant growth and transformation driven by factors such as increasing prevalence of hypertension, technological advancements, and growing awareness about the benefits of renal denervation. The market is characterized by intense competition among various players, including established medical device manufacturers, research institutions, and emerging companies. Technological advancements, collaborations, and research activities are driving innovation in the field and expanding the understanding of renal denervation. However, the market faces challenges such as the lack of long-term clinical evidence, regulatory barriers, and competition from alternative treatment options. Despite these challenges, the market is poised for growth, particularly in regions like Europe and Asia Pacific. The increasing focus on personalized medicine, generation of robust clinical evidence, and expansion into emerging markets are key trends shaping the market. As the market evolves, there is a growing emphasis on patient-centric care and the optimization of renal denervation procedures. With ongoing advancements and research, the renal denervation market holds great potential in revolutionizing hypertension management and improving patient outcomes.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 433.64 million |
| Market size value in 2032 | USD 9370.79 million |
| Growth Rate | 40.7% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Renal Denervation Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Renal Denervation Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Renal Denervation Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Renal Denervation Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Renal Denervation Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Renal Denervation Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
